Eli Lilly and Co (NYSE:LLY)
| 365.61 Delayed Data As of 4:00pm ET |  +0.36 / +0.10%Today’s Change | 231.87 Today|||52-Week Range 369.80 | +32.36% Year-to-Date |
Latest LLY News | Press Releases
| Up 32% in 2022, Is Eli Lilly Stock Still a Buy? Nov 27 / MotleyFool.com - Paid Partner Content | Bristol Myers (BMY) Gains 24.2% YTD: What's in Store for 2023? Nov 21 / Zacks.com - Paid Partner Content |
| Incyte (INCY) Outperforms YTD: Will the Momentum Continue? Nov 25 / Zacks.com - Paid Partner Content | Disney Wins at the Box Office, but Makes Investors Nervous Nov 19 / MotleyFool.com - Paid Partner Content |
| 3 Pharmaceutical Stocks to Invest in This Month Nov 24 / StockNews.com - Paid Partner Content | Zacks Investment Ideas feature highlights: Eli Lilly Nov 18 / Zacks.com - Paid Partner Content |
| Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know Nov 23 / Zacks.com - Paid Partner Content | How Markets Have Fared Under a Divided Congress Nov 17 / Zacks.com - Paid Partner Content |
| Why Shares of Veru Fell 10.33% on Monday Nov 21 / MotleyFool.com - Paid Partner Content | 3 Reasons Eli Lilly Is an Unstoppable Stock Nov 17 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 365.25 |
| Today’s open | 361.05 |
| Day’s range | 361.05 - 369.50 |
| Volume | 2,481,988 |
| Average volume (3 months) | 2,893,544 |
| Market cap | $347.1B |
Data as of 4:00pm ET, 11/28/2022
Growth & Valuation
| Earnings growth (last year) | -9.81% |
| Earnings growth (this year) | -4.36% |
| Earnings growth (next 5 years) | +21.35% |
| Revenue growth (last year) | +15.40% |
| P/E ratio | 55.0 |
| Price/Sales | 8.89 |
| Price/Book | 38.79 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABBVAbbVie | -0.11 | -0.07% |
| PFEPfizer | +0.39 | +0.79% |
| MRKMerck | +0.93 | +0.87% |
| JNJJohnson & Johnson | -0.03 | -0.02% |
Data as of 4:00pm ET, 11/28/2022
Financials
| Next reporting date | February 2, 2023 |
| EPS forecast (this quarter) | $1.95 |
| Annual revenue (last year) | $28.3B |
| Annual profit (last year) | $5.6B |
| Net profit margin | 19.71% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Indianapolis, Indiana |
Forecasts
